PF138 Sigma-AldrichResistin, Human, Recombinant, E. coli
Recommended Products
Overview
| Replacement Information |
|---|
| Product Information | |
|---|---|
| Form | Lyophilized |
| Formulation | Lyophilized from 10 mM sodium citrate, pH 3.0. |
| Quality Level | MQ100 |
| Applications | |
|---|---|
| Application Comments | Endotoxin: ≤ 0.1 ng endotoxin/µg resistin |
| Biological Information | |
|---|---|
| Purity | ≥98% by SDS-PAGE |
| Physicochemical Information | |
|---|---|
| Contaminants | Endotoxin: ≤100 ng/µg |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| PF138 | 0 |
Documentation
Resistin, Human, Recombinant, E. coli SDS
| Title |
|---|
Resistin, Human, Recombinant, E. coli Certificates of Analysis
| Title | Lot Number |
|---|---|
| PF138 |
References
| Reference overview |
|---|
| McTernan, P.G., et al. 2002. J. Clin. Endocrinol. Metab. 87, 2407. Ravussin E., and Smith, S.R. 2002. Ann. N.Y. Acad. Sci. 967, 363. Steppan, C.M., et al. 2001. Nature 409, 307. Way, J.M., et al. 2001. J. Biol. Chem. 276, 25651. |



